利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: To establish the effectiveness and safety of Erbium:YAG (Er:YAG) laser treatment for the management of atrophic and urinary symptoms, due to the so-called Genitourinary Syndrome of Menopause (GSM) and stress incontinence.

Introduction: GSM represents a collection of symptoms and signs associated with aging and a decrease in estrogen and other sex steroids syndrome, including, but not limited to genital symptoms of dryness, burning and irritation; sexual symptoms of lack of lubrication, discomfort or pain, and impaired function; and, urinary symptoms of urgency, dysuria, incontinence and recurrent urinary tract infections.

Materials / method: Patients received three urethral and vaginal laser sessions of a 2940 nm Er:YAG laser in non-ablative mode, using a special vaginal robotic laser probe and a 4 mm intraurethral laser cannula, to promote an improvement in the tropism in both areas.

Results: All patients showed statistically-significant improvement over time during the 12 months following initial laser treatment. The overall improvement determined by VAS showed a great diminishment of the severity of the symptoms. Vaginal pH and MV showed the objective improvement of the vaginal symptoms in all patients. There were no serious adverse events during our study; however, some patients reported a mild discomfort during the laser procedure.

Conclusion: Through many years combined experience involving hundreds of patients, The application of vaginal and urethral non-ablative Er:YAG laser, using a special robotic laser probe and a 4 mm cannula, significantly improved the tropism of both vaginal mucosa and urethral mucosa, and its effects lasted up to 12 months. Randomized, controlled and prospective studies with larger number of patients and longer follow-up are needed to confirm our findings.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Teaching for ViVeve

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： educational grant